EUVIMEDEUVIMED entdecken
Video/Audio

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Charles P Brown, Alan Armstrong, David J Mann

Journal of Visualized Experiments · 2025

DOI: 10.3791/67178 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2025. Verfasst von Charles P Brown und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Imperial College London, Molecular Sciences Research Hub; Department of Life Sciences, Imperial College London, South Kensin…. Hauptthemen laut MEDLINE: Small Molecule Libraries, Drug Discovery. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compounds that form covalent bonds with specific target proteins offer a variety of advantages as chemical probes and therapeutic agents. Most commonly, mildly reactive, electrophilic small molecules are employed to form covalent bonds with select cysteine side chains in specific proteins. Electrophile-first approaches of ligand discovery, whereby a library of electrophilic small molecules are screened against a protein target, have become popular as they avoid the need for time-consuming downstream installation of an electrophilic warhead. Such screening is complicated, however, as electrophilic ligands can exhibit a wide range of different rates of spontaneous reaction with cysteines. Quantitative-irreversible tethering (qIT) offers a fluorescence-based method for hit identification and development that normalizes data for these differences in intrinsic compound reactivity. Rates of reaction of individual compounds with a target protein are determined and compared to compound reactivity with the unstructured tripeptide glutathione (this being a proxy for spontaneous compound reaction), enabling the identification of compounds that preferentially react with the protein of interest. This methodology has been successfully applied to identify selective covalent fragments against several drug targets, including SARS-CoV-2 main protease, cyclin-dependent kinase 2, and RAP27A. Here, we demonstrate the application of qIT to a target protein to generate a quantitative and robust data set, allowing prioritization of hit ligands for future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Molecule LibrariesDrug DiscoverySARS-CoV-2HumansLigandsGlutathioneCysteineCyclin-Dependent Kinase 2Drug Evaluation, Preclinical

Substanzen

Small Molecule LibrariesLigandsGlutathioneCysteineCyclin-Dependent Kinase 2

Autor:innen und Institutionen

  • Department of Chemistry, Imperial College London, Molecular Sciences Research Hub; Department of Life Sciences, Imperial College London, South Kensington Campus.
  • Department of Chemistry, Imperial College London, Molecular Sciences Research Hub.
  • Department of Life Sciences, Imperial College London, South Kensington Campus; d.mann@imperial.ac.uk.

Zitieren

APA

Brown, C. P., Armstrong, A., & Mann, D. J. (2025). Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay. Journal of Visualized Experiments. https://doi.org/10.3791/67178

Vancouver

Brown CP, Armstrong A, Mann DJ. Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay. Journal of Visualized Experiments. 2025. doi:10.3791/67178

BibTeX
@article{Brown2025,
  author = {Brown, Charles P and Armstrong, Alan and Mann, David J},
  title = {Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/67178}
}
Kostenlos starten →